Study guide

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging

Key Takeaways Explain This Topic AI

Fundus autofluorescence (FAF) records stimulated emission from endogenous lipofuscin within retinal pigment epithelium (RPE) secondary lysosomes without requiring exogenous dye injection.

Green FAF (518–532 nm) avoids competitive optical absorption by macular luteal pigment (lutein, zeaxanthin), offering superior subfoveal RPE visualization compared to blue FAF (488 nm).

Pathological hyper-autofluorescence marks active photoreceptor metabolic distress and excessive lipofuscin accumulation, whereas hypo-autofluorescence indicates RPE cell loss, atrophy, or optical blocking.

Ultra-widefield (UWF) scanning laser ophthalmoscopy captures up to 200 degrees of the retina (~82% of surface area) in a single non-contact exposure using ellipsoidal mirror optics.

The UWF Ischemic Index quantifies peripheral capillary non-perfusion in diabetic retinopathy and retinal vein occlusions, directly correlating with neovascularization risk.

Last updated: September 2026

Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging

Clinical Core: Fundus autofluorescence (FAF) provides a non-invasive metabolic functional map of the retinal pigment epithelium (RPE) by imaging the stimulated emission of endogenous fluorophores—predominantly lipofuscin —without intravenous dye injection. Ultra-widefield (UWF) imaging employs ellipsoidal mirror scanning laser technology to expand the diagnostic field of view from standard 30°–50° fields to 200° in a single capture, transforming the management of peripheral non-perfusion, pediatric retinopathies, and chorioretinal dystrophies.

Biophysical Principles of Fundus Autofluorescence

Unlike fluorescein angiography (FA) or indocyanine green angiography (ICGA), which rely on the intravascular injection of exogenous fluorescent dyes, fundus autofluorescence (FAF) exploits the naturally occurring optical fluorescence of intrinsic intracellular compounds within ocular tissues. When exposed to short-wavelength excitation light, these molecules absorb photons and transition to an excited electronic state, subsequently emitting light at a longer, lower-energy wavelength (the Stokes shift ).

The Dominant Fluorophore: Lipofuscin and A2E

The primary source of retinal autofluorescence in the posterior pole is lipofuscin sequestered within the secondary lysosomes of RPE cells:

Cellular Origin: RPE cells continually phagocytose shed photoreceptor outer segment (POS) membranous discs—approximately 10% of outer segment volume per day. Incomplete lysosomal enzymatic digestion of these lipid- and protein-rich membranes, particularly oxidatively damaged polyunsaturated fatty acids and retinoid byproducts from the visual cycle, leads to progressive intracellular lipofuscin deposition.

Biochemical Composition: Lipofuscin is a complex heterogeneous aggregate of lipid-protein complexes and bisretinoid compounds. The most characterized fluorophore is A2E ( N-retinylidene-N-retinylethanolamine ), a hydrophobic quaternary pyridinium bisretinoid formed by the non-enzymatic condensation of two molecules of all- trans -retinal with one molecule of phosphatidylethanolamine in photoreceptor disc membranes.

Phototoxicity: A2E and related bisretinoids are not inert storage products; upon exposure to blue light, they generate reactive oxygen species (ROS), compromise lysosomal membrane integrity, inhibit lysosomal ATPase proton pumps, and trigger RPE cellular apoptosis.

Minor Fluorophores: Additional ocular fluorophores include melanin and melanolipofuscin within RPE and choroidal melanocytes (which emit weak near-infrared autofluorescence), collagen within the sclera and cornea, and calcified hyaline acervuli within optic nerve head drusen .

Excitation Wavelengths: Blue FAF vs. Green FAF

Clinical autofluorescence imaging utilizes two primary wavelength bands, each characterized by distinct optical interactions with ocular media and macular pigments.

  • Imaging Parameter Blue FAF (cSLO) Green FAF (cSLO / Ultra-Widefield)
  • Excitation Wavelength ~488 nm (blue laser) 518 nm – 532 nm (green laser)
  • Barrier Filter Wavelength 500 nm – 680 nm (cut-off ~500–521 nm) 560 nm – 700 nm (cut-off ~560–570 nm)

Macular Luteal Absorption Profound absorption (macular pigment absorbs peak at 450–460 nm) Minimal absorption (bypasses luteal pigment absorption band)

Subfoveal RPE Visualization Obscured by central dark masking High contrast ; permits direct subfoveal RPE evaluation

Optic Disc Drusen Visibility Intense emission, excellent detection Intense emission, excellent detection

Patient Comfort Low (intense blue dazzle induces photophobia and tearing) High (green light is substantially better tolerated)

Cataract Light Scattering Significant anterior media scatter and lens autofluorescence Lower scatter, superior penetration through nuclear sclerosis

Clinical Superiority of Green FAF in Macular Disease

The macular luteal pigments— lutein , zeaxanthin , and meso-zeaxanthin —are concentrated heavily within Henle's fiber layer and the inner plexiform layer of the fovea and parafovea. Because their absorption spectrum peaks sharply between 450 nm and 460 nm and extends to 490 nm, they strongly absorb the 488 nm excitation light of blue FAF. This produces an artificial, pronounced physiological dark zone across the foveal center, blinding the clinician to early subfoveal lipofuscin alterations.

In contrast, green FAF (518–532 nm) shifts the excitation light past the absorption spectrum of macular luteal pigment. Consequently, green FAF allows direct, unhindered visualization of foveal RPE lipofuscin accumulation, enabling early detection of macular telangiectasia type 2, subtle vitelliform lesions, and foveal-sparing geographic atrophy.

Normal FAF Signal Distribution & Anatomical Landmarks

In a healthy adult fundus, the FAF signal exhibits a characteristic, highly reproducible topographic pattern determined by normal tissue architecture and light-filtering structures:

Diffuse Intermediate Gray Background: Physiological lipofuscin turnover in post-mitotic RPE cells generates a homogeneous, medium-intensity gray background across the posterior pole and mid-periphery.

Dark Fovea (Hypo-autofluorescent): In blue FAF, the foveal center is markedly dark due to two optical barriers: (a) selective absorption of excitation light by luteal pigments in Henle's layer, and (b) higher concentration of melanin relative to lipofuscin in subfoveal RPE cells, which acts as a fluorescence absorber.

Profoundly Dark Optic Nerve Head (Hypo-autofluorescent): The optic disc appears jet-black because it consists of unmyelinated axons and lamina cribrosa collagen without an underlying RPE monolayer or lipofuscin granules.

Dark Retinal Blood Vessels (Hypo-autofluorescent): Major arterioles and venules absorb both excitation and emission light due to the broad absorption spectrum of intravascular hemoglobin (oxy- and deoxyhemoglobin absorption peaks at 415 nm [Soret band], 542 nm, and 577 nm), casting a sharp vascular silhouette over the glowing RPE background.

Pathological Autofluorescence Patterns

Pathological alterations on FAF are systematically classified as either hyper-autofluorescence (abnormally increased signal) or hypo-autofluorescence (abnormally decreased signal).

Pathological Pattern Underlying Biophysical Mechanism Characteristic Clinical Conditions

Hyper-Autofluorescence Photoreceptor metabolic stress: Excessive accumulation of unphagocytosed outer segment debris and lipofuscin in distressed RPE Junctional zone of geographic atrophy; early reticular pseudodrusen; acute central serous chorioretinopathy

Subretinal fluorophore pooling: Accumulation of lipofuscin-rich subretinal vitelliform material Best vitelliform macular dystrophy ( BEST1 mutation); adult-onset foveomacular vitelliform dystrophy (AOFVD)

Drug-induced lysosomal dysfunction: Inhibition of lysosomal degradation pathways causing bisretinoid buildup Hydroxychloroquine (Plaquenil) retinal toxicity (parafoveal or pericentral hyper-autofluorescent stress ring)

Direct fluorophore emission: Calcified mucopolysaccharide and protein aggregates Optic nerve head drusen (pre-injection autofluorescence)

Hypo-Autofluorescence Complete RPE cell loss: Total absence of RPE cells and lipofuscin; unmasking of non-fluorescent choroid/sclera Geographic atrophy core in AMD; end-stage Stargardt disease ( ABCA4 ); chorioretinal laser scars

RPE denudation: Physical tear and retraction of the RPE monolayer RPE tear (jet-black bare Bruch's membrane bordered by hyper-autofluorescent retracted RPE roll)

Optical blocking / masking: Blockage of excitation and emission light by superficial opaque materials Preretinal, intraretinal, or subretinal hemorrhage; dense hard exudates; dense pigment clumps; corneal/lens opacities

Clinical Manifestations of Hyper-autofluorescence

Junctional Zone of Geographic Atrophy (GA): In dry age-related macular degeneration (AMD), regions of complete RPE atrophy are frequently surrounded by a perimeter of intense hyper-autofluorescence. This junctional zone represents distressed RPE cells undergoing excessive oxidative stress and phagocytic overload immediately prior to apoptotic collapse. The specific junctional pattern (diffuse trickle, focal, or banded) serves as a validated imaging biomarker predicting the rate of geographic atrophy expansion.

Best Vitelliform Macular Dystrophy: In the vitelliform stage, mutations in the BEST1 gene (encoding bestrophin-1, an RPE basolateral chloride channel) impair POS phagocytosis and fluid transport. Subretinal accumulation of shed outer segment debris and lipofuscin creates a striking, intensely hyper-autofluorescent "egg-yolk" macular lesion.

Early Hydroxychloroquine (Plaquenil) Retinopathy: Hydroxychloroquine binds to melanin within RPE cells, disrupting lysosomal enzymatic activity. In non-Asian patients, early subclinical toxicity produces a distinctive parafoveal hyper-autofluorescent ring (reflecting outer retinal degeneration and RPE metabolic distress), which precedes permanent photoreceptor loss. In Asian patients, toxicity manifests in a wider pericentral pattern following the vascular arcades.

Subretinal Drusenoid Deposits (Reticular Pseudodrusen): Located in the subretinal space above the RPE (unlike conventional drusen located beneath the RPE), reticular pseudodrusen demonstrate characteristic punctate hyper-autofluorescent foci or target-like halos against an intermediate background.

Clinical Manifestations of Hypo-autofluorescence

RPE Tears / Denudation: When a vascularized pigment epithelial detachment (PED) tears in neovascular AMD, the RPE monolayer retracts and rolls up. The bare Bruch's membrane devoid of RPE appears as a sharply demarcated zone of profound hypo-autofluorescence , while the retracted, doubled-up RPE margin displays intense hyper-autofluorescence .

Complete Geographic Atrophy: Confluent RPE cell death results in a window of total signal absence (absolute hypo-autofluorescence), allowing choroidal large-vessel details to become discernible due to absence of RPE masking.

Blocking Defects: Blood absorbs excitation light completely. Preretinal, intraretinal, and subretinal hemorrhages produce absolute hypo-autofluorescence corresponding precisely to the anatomical borders of the hemorrhage.

Ultra-Widefield (UWF) Imaging Principles & Optics

Conventional fundus cameras deliver a 30° to 50° angle of view, capturing approximately 15% of the total retinal surface area. Even when stitched together into a 7-standard field montage (the historic Early Treatment Diabetic Retinopathy Study [ETDRS] protocol), the field of view encompasses only 75° (approximately 30%–34% of the retina).

Ellipsoidal Mirror Optical Geometry

Ultra-widefield (UWF) scanning laser ophthalmoscopes (notably the Optos platform) utilize an engineered ellipsoidal mirror with two focal points:

First Focal Point: Positioned at the scanning laser delivery source inside the instrument.

Second Focal Point: Coincident with the nodal point of the patient's eye (pupil plane).

By pivoting the scanning laser beam through the second focal point at the pupil, the system bypasses the optical aperture limitation of the iris, sweeping across the retina to capture up to 200 degrees internally in a single, non-mydriatic or mydriatic capture. This covers approximately 82% (or up to 200°) of the total retinal surface area in less than 0.5 seconds.

UWF Pseudocolor vs. True-Color Imaging

UWF scanning laser ophthalmoscopy does not use broad-spectrum white flash illumination. Instead, it utilizes two discrete narrow-band laser wavelengths:

Green Laser (532 nm): Penetrates to the sensory retina and RPE, highlighting retinal vasculature, hemorrhages, exudates, and vitreoretinal interface details.

Red Laser (633 nm): Penetrates deeper through the RPE into the choroid, visualizing choroidal nevus margins, melanoma thickness, and choroidal vascular architecture.

Pseudocolor Synthesis: The system digitally merges the 532 nm and 633 nm reflectance scans into a composite "pseudocolor" image. While highly sensitive for vascular and pigmented lesions, the technologist must recognize that colors are synthetic approximations; for instance, retinal hemorrhages appear bright red or dark brown, while optic nerve neuroretinal rim tissue may appear orange-red rather than normal pinkish-orange.

  • Clinical Applications in Peripheral Chorioretinal Disease
  • Diabetic Retinopathy and the UWF Ischemic Index

Approximately 40% of diabetic microvascular pathology lies outside the conventional ETDRS 7-standard fields. UWF reveals predominantly peripheral lesions (PPL) —microaneurysms, hemorrhages, venous beading, and intraretinal microvascular abnormalities (IRMA) located outside the ETDRS fields—in up to 10% of diabetic eyes. Eyes with predominantly peripheral lesions have a 3-fold higher risk of disease progression to proliferative diabetic retinopathy (PDR) and a 4-fold higher risk of developing diabetic macular edema (DME). UWF Ischemic Index (ISI) = Area of Non-Perfused Capillary Retina (pixels or mm 2 ) Total Visible Retinal Area (pixels or mm 2 ) × 100 % \text{UWF Ischemic Index (ISI)} = \frac{\text{Area of Non-Perfused Capillary Retina (pixels or } \text{mm}^2\text{)}}{\text{Total Visible Retinal Area (pixels or } \text{mm}^2\text{)}} \times 100\% UWF Ischemic Index (ISI) = Total Visible Retinal Area (pixels or mm 2 ) Area of Non-Perfused Capillary Retina (pixels or mm 2 ) ​ × 100%

Using ultra-widefield fluorescein angiography (UWF-FA), the Ischemic Index objectively quantifies extensive peripheral capillary non-perfusion, guiding decisions regarding targeted retinal photocoagulation (TRP) versus global panretinal photocoagulation (PRP).

Retinal Vein Occlusion (RVO)

In branch and central retinal vein occlusions, UWF-FA provides comprehensive quantification of peripheral non-perfusion. An ischemic area greater than 10 disc diameters on standard imaging—or an Ischemic Index exceeding 45% on UWF-FA—strongly predicts anterior segment neovascularization (rubeosis iridis) and neovascular glaucoma.

Pediatric Retinopathies (ROP and Coats Disease)

UWF imaging provides non-contact, rapid documentation of peripheral retinal vascularization in Retinopathy of Prematurity (ROP) , accurately mapping the boundary between vascular and avascular retina in Zone I, II, and III, and resolving arteriolar tortuosity and venular dilation in plus disease without corneal contact. In Coats disease , UWF captures peripheral telangiectasias, lightbulb aneurysms, and massive lipid exudation across distant quadrants.

Peripheral Tears and Rhegmatogenous Detachments

UWF readily visualizes peripheral lattice degeneration, atrophic retinal holes, horseshoe tears, operculated holes, and giant retinal tears out to the ora serrata, providing critical preoperative and postoperative documentation for vitreoretinal surgery.

Artifact Management and Patient Alignment Techniques

Achieving diagnostic-quality UWF images requires active operator mitigation of common optical artifacts:

Lid and Lash Shadowing: Long superior or inferior eyelashes and ptotic eyelids block laser transmission, casting thick, curved black or fringed shadows across the upper and lower quadrants.

Correction: Instruct the patient to open wide ("eyes wide like high-beams"); gently elevate the upper lid against the orbital rim with a clean cotton-tipped applicator, ensuring no pressure is placed on the globe; use hypoallergenic surgical tape to retract redundant upper lid skin if necessary.

Pupil Alignment and Decentration: If the patient's pupil is not centered precisely on the second focal point of the ellipsoidal mirror, edge clipping and severe peripheral astigmatic distortion occur.

Correction: Monitor the anterior segment alignment video monitor; ensure the pupil reflection is centered within the target crosshairs and the corneal apex is at the specified working distance.

Eye Steering (Gaze Navigation): While the on-axis scan captures 200°, extreme peripheral pathology near the ora serrata can be brought into central focus by directing the patient's gaze toward external fixation targets (superior, inferior, nasal, and temporal steering), effectively expanding retinal coverage beyond 220°.

Loading diagram... Fundus Autofluorescence (FAF) Signal Assessment & Pathological Patterns